|
|
|
Insider
Information: |
Viswanathan Ravi |
Relationship: |
10% Owner |
City: |
Timonium |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
30 |
|
Direct
Shares |
5,490,582 |
|
Indirect Shares
|
180,638,890 |
|
|
Direct
Value |
$257,830,406 |
|
|
Indirect Value
|
$863,595,769 |
|
|
Total
Shares |
186,129,472 |
|
|
Total
Value |
$1,121,426,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2013-06-03 |
383 |
Premium* |
|
Millennial Media Inc |
MM |
10% Owner |
2012-04-03 |
0 |
2012-10-29 |
8,196,614 |
Premium* |
|
Tesaro, Inc. |
TSRO |
10% Owner |
2012-07-03 |
0 |
2018-03-06 |
739,516 |
Premium* |
|
Workday, Inc. |
WDAY |
10% Owner |
2013-04-09 |
0 |
2013-04-09 |
781 |
Premium* |
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
Epizyme, Inc. |
EPZM |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
6,260,851 |
Premium* |
|
Care.com Inc |
CRCM |
10% Owner |
2014-01-29 |
0 |
2017-11-06 |
336 |
Premium* |
|
Roka Bioscience, Inc. |
ROKA |
10% Owner |
|
0 |
2014-07-22 |
3,216,810 |
Premium* |
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
Box Inc |
BOX |
10% Owner |
|
0 |
2015-01-28 |
0 |
Premium* |
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
|
0 |
2018-05-25 |
3,082,186 |
Premium* |
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2018-09-07 |
12,000,000 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2018-08-21 |
18,698,038 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2018-02-16 |
5,490,073 |
2016-10-31 |
3,490,073 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2017-07-03 |
0 |
2017-07-03 |
8,140,138 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2017-07-24 |
10,989,010 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
2017-10-10 |
0 |
2017-10-10 |
4,909,956 |
Premium* |
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
509 |
2018-02-13 |
1,014 |
Premium* |
|
Elastic N.v. |
ESTC |
10% Owner |
2018-10-10 |
0 |
2018-10-10 |
2,197,503 |
Premium* |
|
Phasebio Pharmaceuticals Inc |
PHAS |
10% Owner |
2018-10-22 |
0 |
2018-10-22 |
6,641,634 |
Premium* |
|
Duolingo, Inc. |
DUOL |
10% Owner |
2022-02-15 |
0 |
2022-07-08 |
6,587 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
124 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AKAO |
Achaogen Inc |
10% Owner |
|
2016-06-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,715,128 |
|
- |
|
AKAO |
Achaogen Inc |
10% Owner |
|
2016-12-19 |
4 |
B |
$13.50 |
$6,750,000 |
I/I |
500,000 |
5,215,128 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2016-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
59,269,000 |
|
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2017-03-27 |
4 |
B |
$0.70 |
$9,009,000 |
I/I |
12,870,000 |
72,139,000 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-21 |
4 |
B |
$1.81 |
$189,820 |
I/I |
104,844 |
72,243,844 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-22 |
4 |
B |
$1.90 |
$1,655,669 |
I/I |
869,574 |
73,113,418 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-23 |
4 |
B |
$1.95 |
$572,358 |
I/I |
294,090 |
73,407,508 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-26 |
4 |
B |
$1.90 |
$1,087,553 |
I/I |
571,164 |
73,978,672 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-27 |
4 |
B |
$1.92 |
$11,500,200 |
I/I |
6,000,000 |
79,978,672 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-09-07 |
4 |
B |
$1.67 |
$25,000,500 |
I/I |
15,000,000 |
12,000,000 |
1.5 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2017-11-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,820,516 |
2,820,516 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2017-11-20 |
4 |
S |
$19.49 |
$54,971,857 |
I/I |
(2,820,516) |
0 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2017-11-27 |
4 |
S |
$19.49 |
$11,101,894 |
I/I |
(569,620) |
0 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2017-11-27 |
4 |
A |
$0.00 |
$0 |
I/I |
569,620 |
569,620 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2018-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,724,202 |
2,724,202 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2018-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
509 |
509 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2018-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
41,877 |
1,014 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2018-02-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,765,065) |
0 |
0 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2015-06-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,803,738 |
|
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2016-01-13 |
4 |
B |
$10.00 |
$10,000,000 |
I/I |
1,000,000 |
1,901,869 |
1.5 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2016-07-18 |
4 |
B |
$8.73 |
$13,333,338 |
I/I |
1,527,301 |
2,665,519 |
1.5 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2018-05-25 |
4 |
A |
$4.00 |
$3,333,332 |
I/I |
833,333 |
3,082,186 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2015-10-20 |
4 |
A |
$0.00 |
$0 |
I/I |
594,245 |
594,245 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2016-05-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,362,694 |
|
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2017-03-28 |
4 |
B |
$0.50 |
$3,000,000 |
I/I |
6,000,000 |
16,362,694 |
1.5 |
- |
|
124 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|